Marinomed Biotech AG Announces Capital Increase

On September 16, 2025, Marinomed Biotech AG revealed a resolution for a capital increase, bypassing statutory subscription rights. The company plans to issue 61,607 no-par value bearer shares, each priced at EUR 17.50. This move will increase the firm's share capital by EUR 61,607, reaching a total of EUR 1,839,940. The capital raise aims to generate EUR 1,078,123 through cash contributions.

Nine investors have already subscribed to all new shares under the specified terms. Marinomed's Supervisory Board swiftly approved the decision post-resolution by the Management Board. The shares will be issued from the authorized capital 2024/II.